Cargando…
Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell(®)
The vast majority of SARS-CoV-2 vaccines which are licensed or under development focus on the spike (S) protein and its receptor binding domain (RBD). However, the S protein shows considerable sequence variations among variants of concern. The aim of this study was to develop and characterize a SARS...
Autores principales: | Rabdano, Sevastyan O., Ruzanova, Ellina A., Pletyukhina, Iuliia V., Saveliev, Nikita S., Kryshen, Kirill L., Katelnikova, Anastasiia E., Beltyukov, Petr P., Fakhretdinova, Liliya N., Safi, Ariana S., Rudakov, German O., Arakelov, Sergei A., Andreev, Igor V., Kofiadi, Ilya A., Khaitov, Musa R., Valenta, Rudolf, Kryuchko, Daria S., Berzin, Igor A., Belozerova, Natalia S., Evtushenko, Anatoly E., Truhin, Viktor P., Skvortsova, Veronika I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141225/ https://www.ncbi.nlm.nih.gov/pubmed/37112786 http://dx.doi.org/10.3390/vaccines11040874 |
Ejemplares similares
-
Antiviral Therapy of COVID-19
por: Gudima, Georgii, et al.
Publicado: (2023) -
Structural and dynamic origins of ESR lineshapes in spin-labeled GB1 domain: the insights from spin dynamics simulations based on long MD trajectories
por: Izmailov, Sergei A., et al.
Publicado: (2020) -
Onset of disorder and protein aggregation due to oxidation-induced intermolecular disulfide bonds: case study of RRM2 domain from TDP-43
por: Rabdano, Sevastyan O., et al.
Publicado: (2017) -
103 Genetic factors defining resistance and susceptibility to HIV/AIDS
por: Kofiadi, IA, et al.
Publicado: (2014) -
Peculiarities of the T Cell Immune Response in COVID-19
por: Kudlay, Dmitry, et al.
Publicado: (2022)